Trifecta outcomes of robotic partial nephrectomy in obese patients: A comparison of body mass index <25, 25 to <30, and ≥30

医学 体质指数 肾切除术 围手术期 置信区间 优势比 逻辑回归 多元分析 内科学 单变量分析 质量指数 外科
作者
Haruyuki Ohsugi,Junichi Ikeda,Kenta Takayasu,Nae Takizawa,Hisanori Taniguchi,Masaaki Yanishi,Hidefumi Kinoshita
出处
期刊:International Journal of Urology [Wiley]
卷期号:31 (10): 1108-1113
标识
DOI:10.1111/iju.15529
摘要

Objective We analyzed robotic partial nephrectomy (RPN) outcomes in obese patients based on body mass index (BMI) and trifecta achievement. Methods We retrospectively reviewed 296 patients who underwent RPN at Kansai Medical University Hospital between 2014 and 2022. The preoperative clinical data and perioperative outcomes were evaluated. Trifecta achievement (negative surgical margin, no major complications, and no acute kidney injury on postoperative day three) and its relationship to three BMI groups (<25, 25 to <30, and ≥30) were the primary outcome. The correlation between factors in achieving trifecta and BMI was evaluated. Univariate and multivariate analyses assessed variables for achieving the trifecta with logistic regression analysis. C‐statistics quantitatively evaluated the prediction accuracy. Results Among 296 patients, 264 (89.2%) achieved trifecta (BMI categories were <25 [89.9%], 25 to <30 [89.4%], and ≥30 [82.6%]). There was no significant BMI‐related difference ( p = 0.566). Intraoperative blood loss increased with the BMI ( p = 0.034). Multivariate analyses showed preoperative aspects and dimensions used for anatomic (PADUA) score independently predicted trifecta failure (odds ratio 1.71; 95% confidence interval 1.32–2.20; p < 0.001). The C‐statistics of the PADUA score increased with increasing BMI. Conclusions Higher BMI patients had more intraoperative blood loss during RPN. However, RPN remains safe and has acceptable quality and functional outcomes. Since patients with high PADUA scores combined with a high BMI may be at risk of trifecta failure, this should be explained before RPN.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
毕不了业的凡阿哥完成签到,获得积分10
刚刚
野子发布了新的文献求助10
刚刚
berry完成签到,获得积分10
1秒前
2秒前
LUNWENREQUEST发布了新的文献求助10
2秒前
大模型应助匹诺曹采纳,获得10
3秒前
ding应助过时的又槐采纳,获得10
4秒前
7秒前
鄙视注册完成签到,获得积分10
8秒前
8秒前
9秒前
9秒前
落寞溪灵完成签到 ,获得积分10
11秒前
玖玖柒idol完成签到,获得积分10
11秒前
曌虞完成签到,获得积分10
11秒前
12秒前
啥,这都是啥完成签到,获得积分10
12秒前
皮皮桂发布了新的文献求助10
13秒前
14秒前
大大发布了新的文献求助10
14秒前
15秒前
orixero应助wang1090采纳,获得30
17秒前
17秒前
l11x29发布了新的文献求助10
19秒前
lin完成签到,获得积分10
19秒前
大侠发布了新的文献求助10
20秒前
20秒前
是锦锦呀完成签到,获得积分10
20秒前
20秒前
李秋静发布了新的文献求助10
21秒前
zhen发布了新的文献求助50
23秒前
是锦锦呀发布了新的文献求助60
23秒前
Khr1stINK发布了新的文献求助10
25秒前
26秒前
NexusExplorer应助Dddd采纳,获得10
28秒前
28秒前
Akim应助zhaowenxian采纳,获得10
29秒前
谦让的鹏煊完成签到,获得积分10
30秒前
zccc完成签到 ,获得积分10
31秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527961
求助须知:如何正确求助?哪些是违规求助? 3108159
关于积分的说明 9287825
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716926
科研通“疑难数据库(出版商)”最低求助积分说明 709808